Harlan F. Weisman, M.D. is the founder and Managing Director of And-One Consulting, LLC, advising medical product companies, investment firms, and government and non-government healthcare organizations in formulating and implementing successful strategies for driving innovation in healthcare products and services. He is co-founder, Board Director and Chief Scientific Officer for Mycrobiomics, Inc. and Executive Chairman of 3DBio Corp. He is also on the board of directors of ControlRad Systems, Inc and Hutchison Biofilm Medical Solutions Ltd, and is an advisor to the Israel Biotechnology Fund, the Johns Hopkins Institute for Basic Biomedical Sciences, Memorial Sloan Kettering Cancer Center and BioMotiv, a medical product accelerator company.
Previously, Dr. Weisman was Chairman and CEO of Coronado Biosciences, Inc., a company focused on developing treatments for immune mediated inflammatory disorders. Prior to Coronado, he served over 20 years as a senior executive at Johnson & Johnson including as Chief Science and Technology Officer of the J&J Medical Devices Group, Company Group Chairman, J&J Pharmaceutical Research & Development, President of Centocor R&D and also served on the board of directors of J&J Development Corporation (JJDC). Before joining industry, Dr. Weisman was Assistant Professor of Medicine and Director of the Experimental Cardiac Pathology Laboratory at the Johns Hopkins University School of Medicine, and Consultant Cardiologist at Johns Hopkins Hospital.
Dr. Weisman has authored more than 100 articles and book chapters about cardiovascular disease, medical product development, healthcare policy and organizational development. He is a frequent invited speaker at international meetings on medical innovation, health policy and product development strategy.